The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 28, 2025
Filed:
Aug. 01, 2022
Applicant:
Xwpharma Ltd., Grand Cayman, KY;
Inventors:
Jia-Ning Xiang, Fremont, CA (US);
Xuesong Xu, Fremont, CA (US);
Hao-Wei Shih, New Taipei, TW;
Wai-Si Eng, Maple Glen, PA (US);
Assignee:
XWPHARMA LTD., Grand Cayman, KY;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 271/24 (2006.01); A61K 9/00 (2006.01); A61K 31/165 (2006.01); A61K 31/166 (2006.01); C07C 211/35 (2006.01); C07C 271/56 (2006.01); C07D 213/80 (2006.01); C07D 305/06 (2006.01); C07D 309/08 (2006.01); C07D 317/68 (2006.01); C07D 207/16 (2006.01); C07D 207/28 (2006.01); C07D 211/62 (2006.01);
U.S. Cl.
CPC ...
C07C 271/24 (2013.01); A61K 9/0053 (2013.01); A61K 31/165 (2013.01); A61K 31/166 (2013.01); C07C 211/35 (2013.01); C07C 271/56 (2013.01); C07D 213/80 (2013.01); C07D 305/06 (2013.01); C07D 309/08 (2013.01); C07D 317/68 (2013.01); C07D 207/16 (2013.01); C07D 207/28 (2013.01); C07D 211/62 (2013.01);
Abstract
Ketamine derivatives and pharmaceutical compositions thereof are disclosed. When administered orally the ketamine derivatives provide increased bioavailability of ketamine in the systemic circulation. The ketamine derivatives can be used to treat neurological diseases, psychological diseases and pain.